Old North State Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-886
Closed -$70K 326
2023
Q1
$70K Buy
886
+56
+7% +$3.97K 0.05% 222
2022
Q4
$56K Hold
830
0.04% 234
2022
Q3
$41K Buy
+830
New +$44.5K 0.04% 229
2022
Q1
Sell
-876
Closed -$49K 269
2021
Q4
$49K Buy
876
+626
+250% +$33.9K 0.04% 226
2021
Q3
$12K Hold
250
0.01% 283
2021
Q2
$10K Hold
250
0.01% 303
2021
Q1
$8K Hold
250
0.01% 302
2020
Q4
$9K Hold
250
0.01% 303
2020
Q3
$9K Buy
+250
New +$8.33K 0.01% 292

Other funds holding NVO

Old North State Trust's NVO Position: Q2 2023 in Review

Old North State Trust sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 886 shares — an estimated $70K sold.

Old North State Trust first reported a position in NVO in Q3 2020 and held it in 9 quarters. The position peaked at $70K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Old North State Trust reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
  • Old North State Trust sold 886 Novo Nordisk shares in Q2 2023, an estimated $70K.
  • Old North State Trust first reported a position in Novo Nordisk in Q3 2020 and held it in 9 quarters.
  • Old North State Trust's Novo Nordisk position peaked at $70K in Q1 2023.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Old North State Trust's 13F filing for Q2 2023, filed 22 Aug 2023.